✦ LIBER ✦

Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes

✍ Scribed by Ross, Stuart A.; Ballantine, Jane

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of type 2 diabetes with glucag

✍ K. B. Hansen; F. K. Knop; J. J. Holst; T. Vilsbøll 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Glucagon-like peptide-1 (GLP-1) receptor

✍ D. J. Drucker; C. F. Rosen 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 130 KB

A glucagon-like peptide-1 (GLP-1) recept

✍ S. K. Thondam; D. J. Cuthbertson; B. S. Aditya; I. A. MacFarlane; J. P. Wilding; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Rationale Use of GLP-1 Receptor Agonists

✍ Unger, Jeff 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 349 KB

Glucagon-like peptide-1 receptor agonist

✍ Lund, Asger; Knop, Filip K.; Vilsbøll, Tina 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Clinical decision making in diabetes: Us

✍ Freeman, Jeffrey S. 📂 Article 📅 2013 🏛 The American College of Osteopathic Family Physici 🌐 English ⚖ 104 KB